Massmutual Trust CO Fsb Harmony Biosciences Holdings, Inc. Transaction History

Massmutual Trust CO Fsb

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 03, 2023	BUY	$31.89 - $39.03 $95 - $117	3 Added 4.41%	71 $2,000
Q2 2023 Aug 01, 2023	BUY	$30.5 - $37.4 $1,159 - $1,421	38 Added 126.67%	68 $2,000
Q1 2023 Apr 11, 2023	SELL	$30.8 - $53.92 $1,570 - $2,749	-51 Reduced 62.96%	30 $0
Q4 2022 Jan 06, 2023	BUY	$45.4 - $60.91 $771 - $1,035	17 Added 26.56%	81 $4,000
Q3 2022 Oct 07, 2022	BUY	$42.06 - $55.45 $1,177 - $1,552	28 Added 77.78%	64 $3,000
Q2 2022 Jul 07, 2022	BUY	$33.54 - $52.15 $402 - $625	12 Added 50.0%	36 $2,000
Q1 2022 Apr 08, 2022	SELL	$33.14 - $51.13 $463 - $715	-14 Reduced 36.84%	24 $1,000
Q4 2021 Feb 09, 2022	BUY	$34.09 - $43.91 $477 - $614	14 Added 58.33%	38 $2,000
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $179 - $270	7 Added 41.18%	24 $1,000
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $441 - $568	17 New	17 $0

254

46.6M

119K

50K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.19B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.